Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)

ClinicalTrials.gov ID: NCT01060878

Public ClinicalTrials.gov record NCT01060878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 8:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Tolerability of PYM50028 in Subjects With Early-stage Parkinson's Disease Administered Once Daily for 28 Weeks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to test the therapeutic benefit of the compound PYM50028, versus placebo, in treating early-stage Parkinson's disease. Therapeutic benefit will be assessed using the Unified Parkinson's Disease Rating Scale (UPDRS). It is hypothesised that PYM50028 will be safe and well tolerated in this study and demonstrate therapeutic benefit in this patient population.

Study identification

NCT ID
NCT01060878
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Phytopharm
Industry
Enrollment
425 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2010
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Mar 3, 2013

2010 – 2012

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
40
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona 85259
University of California, Irvine Irvine California 92697
Coastal Neurological Medical Group La Jolla California 92037
Cedars Sinai Medical Center Los Angeles California 90048
Pacific Neuroscience Oxnard California 93030
Ellison Ambulatory Care Center Sacramento California 95817
The Parkinson's Institute Sunnyvale California 94085
Colorado Neurological Institute, Rocky Mountain Movement Disorders Center Englewood Colorado 80113
Hartford Hospital Manchester Connecticut 06040
Institute for Neurodegenerative Disorders New Haven Connecticut 06510
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
University of Florida Center for Movement Disorders and Neurorestoration Gainesville Florida 32607
Neurology Clinical Research Inc Sunrise Florida 33351
University of South Florida Tampa Florida 33606
Emory University Atlanta Georgia 30329
Medical College of Georgia Augusta Georgia 30912
Elks Rehab - Movement Disorders Center Boise Idaho 83702
Northwestern University Chicago Illinois 60611
Rush University Medical Center Neuroscience Inst. Chicago Illinois 60612
Southern Illinois University School of Medicine Springfield Illinois 62794
The University of Kansas Medical Center Kansas City Kansas 66160
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Henry Ford Health Center West Bloomfield Michigan 48322
Struthers Parkinson's Center Golden Valley Minnesota 55427
Washington University School of Medicine St Louis Missouri 63110
Atlantic Neuroscience Institute Morristown New Jersey 07902
Robert Wood Johnson Medical School New Brunswick New Jersey 08901
North Shore University Hospital Manhasset New York 11030
Weil Medical College of Cornell University New York New York 10021
Duke Parkinson Center Durham North Carolina 27705
University of Cincinnati Physicians Cincinnati Ohio 45219
Neurological Institute, Cleveland Clinic Cleveland Ohio 44195
University of Toledo Toledo Ohio 43614
University of Pennsylvania Philadelphia Pennsylvania 19107
University of Pittsburgh Pittsburgh Pennsylvania 15260
Medical University of South Carolina Charleston South Carolina 29401
University of Tennessee Health Science Center Memphis Tennessee 38163
Baylor College of Medicine Houston Texas 77030
University of Utah Salt Lake City Utah 84108
University of Virginia Adult Neurology Charlottesville Virginia 22903
Wisconsin Institute for Neurologic and Sleep Disorders Milwaukee Wisconsin 53233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01060878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2013 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01060878 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →